Lv4
480 积分 2023-06-06 加入
Clinicopathological characteristics of pure red cell aplasia induced by immune checkpoint inhibitors in cancer patients
1个月前
已完结
Penpulimab and Gemcitabine With or Without Anlotinib in Metastatic Nasopharyngeal Carcinoma: A Randomized, Open‐Label, Multicenter Phase 2 Study
1个月前
已完结
Anlotinib plus penpulimab: a new contender in first-line therapy for unresectable hepatocellular carcinoma
1个月前
已关闭
Efficacy of radiotherapy to metastatic lesion in de novo metastatic nasopharyngeal carcinoma patients: A multicenter, propensity score matching study
2个月前
已关闭
Current advances and clinical perspectives of anti-angiogenic therapy combined with immune checkpoint inhibitors in digestive system malignancies
2个月前
已完结
New Toxicity Signals Associated With Ixekizumab
3个月前
已完结
Forty-eight-week safety of bimekizumab in psoriasis: focus on infectious comorbidities
3个月前
已完结
Systemic bleeding risk assessment, inflammatory and metabolic markers: reconsidering impact of PCSK9 inhibitors on bleeding and adverse outcomes in post-PCI patients undergoing antiplatelet therapy
5个月前
已关闭
Clinical pathway for the diagnosis and treatment of moderate to severe atopic dermatitis in China （2023）: an expert consensus
5个月前
已完结
Phenotypes of Atopic Dermatitis and Development of Allergic Diseases
6个月前
已完结
皖公网安备34019202002308
